Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

The convention discussed various skin conditions, treatments, and the importance of continuous learning in dermatology nursing.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

Erosive pustular dermatosis is a rare skin disease that's hard to treat and affects the scalp or legs.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

The document concludes that surgery is a preferred treatment for cicatricial alopecia, with the method chosen based on individual factors and may require multiple sessions and careful postoperative care.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Use antiandrogens and other treatments for hair loss.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Adults with atopic dermatitis showed similar adherence to different forms of hydrocortisone cream, but actual use varied despite self-reports of near-perfect usage.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Skin symptoms can indicate endocrine disorders and have various treatments.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Proper education can prevent traction alopecia in women of color.